The Online Investor
Drugs & Pharmaceuticals M&A image Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Fri., Dec. 3, 6:06 PM Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.

Slide #87. Prestige Brands Holdings, Inc. Care Pharmaceuticals

Acquirer: Prestige Brands Holdings, Inc. (NYSE:PBH)
Acquiree: Care Pharmaceuticals
Details: Prestige Brands Holdings, Inc. (NYSE:PBH) today announced its acquisition of Care Pharmaceuticals Pty Ltd. ("Care") of Bondi Junction, New South Wales, Australia, a privately-held marketer and distributor of over-the-counter (OTC) healthcare brands for children and adults. The acquisition is effective July 1, 2013.

Prestige Consumer Healthcare is a holding company. Through its subsidiaries, Co. develops, manufactures, markets, sells and distributes over-the-counter (OTC) healthcare products to mass merchandisers and drug, food, dollar, convenience, club and e-commerce stores in North America and in Australia and certain other international markets. Co.'s portfolio of OTC Healthcare products includes, among others, Clear Eyes eye and ear care products, Compound W wart removal, Chloraseptic sore throat liquids and lozenges, DenTek oral care products, Luden's cough drops, Monistat women's health products, Nix lice and parasite treatment products and Fess Nasal Saline Sprays and Washes.

PBH SEC Filing Email Alerts Service


Open the PBH Page at The Online Investor »

Company Name: 
Prestige Consumer Healthcare Inc
Stock buyback: 
PBH buyback
Website: 
www.prestigeconsumerhealthcare.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding PBH: 
61
Total Market Value Held by ETFs: 
$728.90M
Total Market Capitalization: 
$2.80B
% of Market Cap. Held by ETFs: 
26.00%
 

Open the PBH Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree PBH Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.50 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)

Analysts' Target Price:
PBH Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Drugs & Pharmaceuticals M&A - Slide 87 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.